LOWELL, Mass., March 25, 2019 /PRNewswire-PRWeb/ -- The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 8th annual $200K Challenge after reviewing a record-setting 150+ applications.
The 21 finalists, all early-stage medical device, diagnostic, and biotech companies, will be eligible for a share of $200,000 in sponsor-provided, in-kind services. These services can include use of facilities including lab and office space; and engineering, product development, legal, regulatory, clinical, and business services.
M2D2 assists entrepreneurs in the medical-device and biotech sector in moving new products from concept to commercialization. It is a joint venture of University of Massachusetts Medical School, which provides medical expertise and assistance with clinical trials, and the University of Massachusetts Lowell, which offers expertise in business and engineering. M2D2 has three locations, two in Lowell and one on the campus of the UMass Medical School.
The 2019 $200K Challenge sponsors are Johnson & Johnson Innovation, the Massachusetts Life Sciences Center, Amgen, Boston Scientific, Mintz, MPR Product Development, R&Q (Regulatory & Quality Solutions), Hologic, Asahi Intecc, and the Deshpande Foundation.
This year's Challenge finalists are:
ARO Buzzing Technologies CardioCorX Childrens National Dynocardia EnClear Therapies Endovascular Engineering EnLisense Gynion IMOV Kinnos Leon Scientific MediSim Neurovascular Diagnostics NPT Rapid Testing Respirix Rithim Biologics Teratonix Thoreau Labs UroMonitor UroRelief
All finalists will display and demonstrate their ideas at the M2D2 Challenge Finalist Pitch-Off on Wednesday, March 27 at 5:00 pm at UMass Lowell's University Crossing. The Challenge winners will be announced on Wednesday, April 10 at 5:00 pm at an Awards & Networking event hosted by Mintz in Boston.
Tickets can be purchased for either or both events at: https://www.eventbrite.com/e/2019-m2d2-200k-challenge-finalist-showcase-pitch-off-events-tickets-56587606053
About M2D2 M2D2, the Massachusetts Medical Device Development Center, is a joint initiative of the Lowell and Worcester campuses of the UMass system. Its aim is to help new biotech and medical device entrepreneurs develop products every step of the way, from proof-of-concept to commercialization. Affiliated faculty and staff have assisted more than 100 start-up companies and entrepreneurs since the program kicked off in the spring of 2007. http://www.uml.edu/m2d2
Media contacts:
Christine Gillette 978-934-2209 [email protected]
Nancy Cicco 978-934-4944 [email protected]
SOURCE University of Massachusetts at Lowell
Advertisement
The 21 finalists, all early-stage medical device, diagnostic, and biotech companies, will be eligible for a share of $200,000 in sponsor-provided, in-kind services. These services can include use of facilities including lab and office space; and engineering, product development, legal, regulatory, clinical, and business services.
Advertisement
M2D2 assists entrepreneurs in the medical-device and biotech sector in moving new products from concept to commercialization. It is a joint venture of University of Massachusetts Medical School, which provides medical expertise and assistance with clinical trials, and the University of Massachusetts Lowell, which offers expertise in business and engineering. M2D2 has three locations, two in Lowell and one on the campus of the UMass Medical School.
The 2019 $200K Challenge sponsors are Johnson & Johnson Innovation, the Massachusetts Life Sciences Center, Amgen, Boston Scientific, Mintz, MPR Product Development, R&Q (Regulatory & Quality Solutions), Hologic, Asahi Intecc, and the Deshpande Foundation.
This year's Challenge finalists are:
ARO Buzzing Technologies CardioCorX Childrens National Dynocardia EnClear Therapies Endovascular Engineering EnLisense Gynion IMOV Kinnos Leon Scientific MediSim Neurovascular Diagnostics NPT Rapid Testing Respirix Rithim Biologics Teratonix Thoreau Labs UroMonitor UroRelief
All finalists will display and demonstrate their ideas at the M2D2 Challenge Finalist Pitch-Off on Wednesday, March 27 at 5:00 pm at UMass Lowell's University Crossing. The Challenge winners will be announced on Wednesday, April 10 at 5:00 pm at an Awards & Networking event hosted by Mintz in Boston.
Tickets can be purchased for either or both events at: https://www.eventbrite.com/e/2019-m2d2-200k-challenge-finalist-showcase-pitch-off-events-tickets-56587606053
About M2D2 M2D2, the Massachusetts Medical Device Development Center, is a joint initiative of the Lowell and Worcester campuses of the UMass system. Its aim is to help new biotech and medical device entrepreneurs develop products every step of the way, from proof-of-concept to commercialization. Affiliated faculty and staff have assisted more than 100 start-up companies and entrepreneurs since the program kicked off in the spring of 2007. http://www.uml.edu/m2d2
Media contacts:
Christine Gillette 978-934-2209 [email protected]
Nancy Cicco 978-934-4944 [email protected]
SOURCE University of Massachusetts at Lowell
